Holen Sie sich die Stockscreener-App
10.01
1.93%
0.19
Handel nachbörslich:
10.01
Schlusskurs vom Vortag:
$9.82
Offen:
$9.77
24-Stunden-Volumen:
646.30K
Relative Volume:
0.83
Marktkapitalisierung:
$1.30B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$5.00M
KGV:
-
EPS:
-
Netto-Cashflow:
$-383.00M
1W Leistung:
-4.76%
1M Leistung:
+16.94%
6M Leistung:
-41.01%
1J Leistung:
-40.42%
1-Tages-Spanne:
$9.62
$10.05
1-Wochen-Bereich:
$9.62
$10.40
52-Wochen-Spanne:
$7.33
$23.22
Indivior Plc Stock (INDV) Company Profile
Vergleichen Sie INDV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| INDV | 10.01 | 1.30B | 1.12B | 5.00M | -383.00M | 0.00 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-13 | Eingeleitet | Northland Capital | Outperform |
Indivior Plc Aktie (INDV) Neueste Nachrichten
Indivior’s Voting Rights Shift with Madison Avenue - TipRanks
Suboxone Tooth Decay Lawsuit - Lawsuit Information Center Blog
A Piece Of The Puzzle Missing From Indivior PLC's (LON:INDV) 35% Share Price Climb - Simply Wall St
SCOPIA CAPITAL MANAGEMENT LP Adjusts Stake in Indivior PLC - GuruFocus.com
Indivior Extends Board Tenure Amidst Shareholder Changes - TipRanks
Richmond InnoChesterfield pharma company Indivior subject to activist shareholder push - The Business Journals
Learn to Evaluate (INDV) using the Charts - Stock Traders Daily
Indivior PLC (INDV) Shares Down 3.04% on Nov 12 - GuruFocus.com
Deerfield’s Strategic Stake Acquisition in Indivior - TipRanks
Indivior jumps amid investor letter, takeover speculation (update) - MSN
Indivior (LON:INDV) Shares Pass Below 200-Day Moving AverageShould You Sell? - MarketBeat
Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior - The Malaysian Reserve
Indivior Boosts Shareholder Value with Repurchase Program - TipRanks
Oaktree Capital urges UK's Indivior to refresh board - Reuters
Indivior says it remains open-minded on activist investor Oaktree's proposals - Proactive Investors USA
Indivior Engages with Oaktree on Value Proposals - TipRanks
Indivior jumps amid takeover speculation - MSN
Oaktree Capital calls on Indivior to refresh board of directors - ShareCast
A Setback for Suboxone Film Plaintiffs: Northern District of Ohio's Dismissal Decision - LawyersandSettlements.com
AlphaCentric Advisors LLC Invests $2.36 Million in Indivior PLC (NASDAQ:INDV) - MarketBeat
Indivior completes refinancing of secured term loan - Marketscreener.com
Indivior Extends Its Debt Maturity With Refinancing of Term Loan - Bloomberg
Indivior Boosts Liquidity with $400 Million Refinancing - TipRanks
Indivior PLC Completes Refinance of Secured Term Loan - Marketscreener.com
VELA Investment Management LLC Acquires 108,435 Shares of Indivior PLC (NASDAQ:INDV) - MarketBeat
When the Price of (INDV) Talks, People Listen - Stock Traders Daily
Indivior Announces Total Voting Rights Update - TipRanks
Indivior (LON:INDV) Stock Price Crosses Below 200 Day Moving AverageWhat's Next? - MarketBeat
Sublocade shows promise in opioid disorder recovery By Investing.com - Investing.com Australia
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month - The Malaysian Reserve
Sublocade shows promise in opioid disorder recovery - Investing.com India
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Ab - StreetInsider.com
Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month – Company Announc - Financial Times
Indivior PLC Strengthens Position with Share Buyback - TipRanks
Mediolanum International Funds Ltd Purchases Shares of 124,624 Indivior PLC (NASDAQ:INDV) - MarketBeat
Indivior's (INDV) Overweight Rating Reiterated at Piper Sandler - MarketBeat
Indivior price target raised to $16 from $15 at Piper Sandler - TipRanks
Indivior stock target increased, overweight on strong earnings By Investing.com - Investing.com UK
Indivior PLC (INDV) Surpasses Q3 Earnings and Revenue Estimates - MSN
Earnings call: Indivior PLC reports strong Q3 revenue growth, eyes expansion - Investing.com Nigeria
Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive ... - Yahoo Finance
Indivior PLC (INDV) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Competitive ... By GuruFocus - Investing.com Canada
Indivior Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Indivior (NASDAQ:INDV) Shares Gap UpWhat's Next? - MarketBeat
Severn Trent, Bloomsbury, Indivior: What brokers said today - Proactive financial news
Finanzdaten der Indivior Plc-Aktie (INDV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):